Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:19 PM
Ignite Modification Date:
2025-12-24 @ 10:19 PM
NCT ID:
NCT00899535
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of non-small cell carcinoma
* Primary, untreated disease
* Stage I or II (T1 or T2, N0 or non-hilar N1, M0) disease
* Any of the following histologies allowed:
* Squamous cell carcinoma
* Adenocarcinoma (\< 10%)
* Large cell carcinoma (high-grade)
* Available tumor tissue samples collected on clinical trial ACOSOG-Z0030 and meeting the following criteria:
* Snap-frozen and stored at a temperature of -80°C or lower
* Specimens may come from any site within the lung or one that is involved by direct regional extension of tumor from the originating site in the lung
* No regional lymph node or distant metastases
* No recurrent or persistent disease after prior neoadjuvant or adjuvant treatment for lung cancer
* Must have matching frozen samples of normal tissue and blood
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00899535
Study Brief:
Protocol Section:
NCT00899535